Details of the Drug
General Information of Drug (ID: DMV10UH)
Drug Name |
GNF-PF-4421
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
GNF-PF-4421; 85418-73-1; 6-Ethyl-4-hydroxyquinoline-3-carboxylic acid ethyl ester; AURORA 17945; ethyl 6-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylate; ethyl 6-ethyl-4-hydroxyquinoline-3-carboxylate; AC1LECY7; Oprea1_563397; Oprea1_408052; CHEMBL206540; SCHEMBL7291769; SCHEMBL11066821; CTK8F7131; DTXSID00350618; ZFOFJXFVCJQXBL-UHFFFAOYSA-N; MolPort-003-761-637; MolPort-000-653-080; ZINC9761169; STK791819; MMV007116; STK942448; 3-Quinolinecarboxylic acid, 6-ethyl-1,4-dihydro-4-oxo-, ethyl ester; AKOS002674049; AKOS001717599
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 245.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||||||||||||